Marvin & Palmer Associates Has Lowered By $3.12 Million Its Blackstone Group LP (BX) Stake; Selecta Biosciences (SELB) Shorts Decreased By 7.35%

February 18, 2018 - By Kurt Siggers

Selecta Biosciences Incorporated (NASDAQ:SELB) had a decrease of 7.35% in short interest. SELB’s SI was 1.60M shares in February as released by FINRA. Its down 7.35% from 1.72 million shares previously. With 264,500 avg volume, 6 days are for Selecta Biosciences Incorporated (NASDAQ:SELB)’s short sellers to cover SELB’s short positions. The stock decreased 0.12% or $0.01 during the last trading session, reaching $8.5. About 163,330 shares traded. Selecta Biosciences, Inc. (NASDAQ:SELB) has 0.00% since February 18, 2017 and is . It has underperformed by 16.70% the S&P500.

Marvin & Palmer Associates Inc decreased Blackstone Group Lp (BX) stake by 47.17% reported in 2017Q3 SEC filing. Marvin & Palmer Associates Inc sold 94,576 shares as Blackstone Group Lp (BX)’s stock declined 1.16%. The Marvin & Palmer Associates Inc holds 105,939 shares with $3.54 million value, down from 200,515 last quarter. Blackstone Group Lp now has $40.96B valuation. The stock decreased 0.40% or $0.14 during the last trading session, reaching $34.51. About 3.45M shares traded. The Blackstone Group L.P. (NYSE:BX) has risen 20.49% since February 18, 2017 and is uptrending. It has outperformed by 3.79% the S&P500.

Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company, researches and develops nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. The company has market cap of $189.86 million. The Company’s lead product candidate is SEL-212, which is in phase I/II clinical trials for the treatment of refractory and chronic tophaceous gout. It currently has negative earnings.

Investors sentiment decreased to 1.24 in Q3 2017. Its down 0.40, from 1.64 in 2017Q2. It dropped, as 29 investors sold BX shares while 155 reduced holdings. 52 funds opened positions while 177 raised stakes. 272.94 million shares or 3.67% less from 283.35 million shares in 2017Q2 were reported. The New York-based M&T Savings Bank has invested 0.01% in The Blackstone Group L.P. (NYSE:BX). Walleye Trading Ltd Liability Company has 0.01% invested in The Blackstone Group L.P. (NYSE:BX). Quinn Opportunity Partners Limited has invested 0.23% in The Blackstone Group L.P. (NYSE:BX). Whittier owns 10,984 shares. Baldwin Management Ltd Liability accumulated 11,450 shares. Acg Wealth owns 18,607 shares. Deutsche Bank Ag invested 0.08% of its portfolio in The Blackstone Group L.P. (NYSE:BX). 19,530 were reported by Chesapeake Asset Mngmt Limited Liability Company. California Public Employees Retirement Systems, California-based fund reported 1.17M shares. Paw holds 0.53% or 15,000 shares. New Jersey-based Strategy Asset Managers Ltd Company has invested 0.18% in The Blackstone Group L.P. (NYSE:BX). Gardner Lewis Asset Mgmt Limited Partnership holds 0.2% of its portfolio in The Blackstone Group L.P. (NYSE:BX) for 92,555 shares. Amer Financial Group reported 392,000 shares. Barrett Asset Limited Liability Co invested in 154,379 shares. Aviance Ptnrs Limited Liability Corp owns 34,424 shares.

Since December 13, 2017, it had 0 buys, and 1 insider sale for $632,896 activity. Shares for $632,896 were sold by Finley John G on Wednesday, December 13.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: